CN3 HEALTH ECONOMIC EVALUATION BASED ON THE 5-YEAR COMPLETED TREATMENT ANALYSIS OF THE ATAC TRIAL COMPARING ANASTROZOLE VERSUS TAMOXIFEN IN ADJUVANT TREATMENT OF POSTMENOPAUSAL HORMONE RECEPTOR POSITIVE EARLY BREAST CANCER

Nov 1, 2005, 00:00 AM
10.1016/S1098-3015(10)67205-1
https://www.valueinhealthjournal.com/article/S1098-3015(10)67205-1/fulltext
Section Title :
Section Order : 392
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)67205-1&doi=10.1016/S1098-3015(10)67205-1
HEOR Topics :
Tags :
Regions :